Serene attended the Society of Nucelar Medicine and Molecular Imaging Annual Meeting in Denver, Colorado, where two presentations were accepted: a poster entitled "External radiation exposure following Sn-117m colloid intra-articular injections" and a presentation entitled "A comparison of tissue doses…
A poster entitled "External radiation exposure following Sn-117m colloid intra-articular injections," and an oral presentation entitled "A comparison of tissue doses from colloidal Sn-117m, Re-186, Y-90 and Er-169 for radiosynoviorthesis using Monte Carlo simulation," have been accepted for the Society…
Serene is pleased to announce that it has completed the enrollment of a pivotal trial of its lead product, Synovetin OA, in a trial of naturally occurring canine elbow osteoarthritis. Synovetin OA is a proprietary Sn-117m colloid used for the…
Serene, LLC was the featured company profile in the "My Biz in Isotopes" section of the February 2017 Newsletter edition.
Serene's commercial manufacturing facility located at Theragenics Corporation is completing processes and procedures to supply Synovetin OA. Validations currently underway will be completed within the next few weeks in time to support all future trials and commercial demands.
Serene submitted two abstracts to SNMMI annual meeting June 10-14, 2017, in Denver Colorado. Abstracts are entitled "A comparison of tissue doses from colloidal Sn-117m, Re-186, Y-90 and Er-169 for radiosynoviorthesis using Monte Carlo simulation," and "External radiation exposure following…
An abstract entitled "Preclinical Evaluation of 117mSn Colloid as a Radiosynoviorthesis Agent for Treatment of Canine Elbow Joint Osteoarthrosis" has been accepted for Podium Presentation at the Veterinary Orthopedic Society Annual Meeting at Snowbird, US on March 13, 2017.
Jay Donecker, VMD, will present a Podium Presentation entitled "Synovitis and Radiosynoviorthesis" at the Association for Veterinary Orthopedic Research and Education Winter Meeting in San Diego on January 27, 2017.
Two posters and one oral presentation related to Serene data were presented at the World Association of Radiopharmaceutical and Molecular Therapy 11th International Conference on Radiopharmaceutical Therapy in Cochi, India, between November 13-16. Dr Stevenson's presentation was awarded a prize for…
Serene Chief Operating Officer, Nigel Stevenson, has been named as a Session Chairperson at the 9th International Conference on Isotopes & Expo in Doha, Qatar, November 12-16, 2017.